AU7896700A - Methods to identify compounds that modulate neuronal activity - Google Patents

Methods to identify compounds that modulate neuronal activity

Info

Publication number
AU7896700A
AU7896700A AU78967/00A AU7896700A AU7896700A AU 7896700 A AU7896700 A AU 7896700A AU 78967/00 A AU78967/00 A AU 78967/00A AU 7896700 A AU7896700 A AU 7896700A AU 7896700 A AU7896700 A AU 7896700A
Authority
AU
Australia
Prior art keywords
methods
identify compounds
neuronal activity
modulate neuronal
modulate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU78967/00A
Other languages
English (en)
Inventor
Terrance P. Snutch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
BRITISH COLOMBIA, University of
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BRITISH COLOMBIA, University of, University of British Columbia filed Critical BRITISH COLOMBIA, University of
Publication of AU7896700A publication Critical patent/AU7896700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70571—Assays involving receptors, cell surface antigens or cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU78967/00A 1999-10-13 2000-10-13 Methods to identify compounds that modulate neuronal activity Abandoned AU7896700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15909599P 1999-10-13 1999-10-13
US60159095 1999-10-13
PCT/CA2000/001233 WO2001027630A2 (en) 1999-10-13 2000-10-13 Methods to identify compounds that modulate neuronal activity

Publications (1)

Publication Number Publication Date
AU7896700A true AU7896700A (en) 2001-04-23

Family

ID=22571069

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78967/00A Abandoned AU7896700A (en) 1999-10-13 2000-10-13 Methods to identify compounds that modulate neuronal activity

Country Status (9)

Country Link
US (1) US6531288B1 (enExample)
EP (1) EP1230551B1 (enExample)
JP (1) JP2003511087A (enExample)
AT (1) ATE312350T1 (enExample)
AU (1) AU7896700A (enExample)
CA (1) CA2385907A1 (enExample)
DE (1) DE60024664T2 (enExample)
ES (1) ES2253263T3 (enExample)
WO (1) WO2001027630A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2424269T3 (es) * 2002-11-01 2013-09-30 Iris International, Inc. Inmuno-PCR sándwich por desplazamiento
US20050266524A1 (en) * 2003-12-03 2005-12-01 Bulla Lee A Beta integrin gene and protein
JP5188808B2 (ja) * 2004-11-03 2013-04-24 アイリス モレキュラー ダイアグノスティクス， インコーポレイテッド 同種の分析物検出
PT1815028E (pt) * 2004-11-03 2012-01-24 Iris Molecular Diagnostics Inc Microbolhas para separação por afinidade
US20090246781A1 (en) * 2008-02-21 2009-10-01 Robert Klem Method for early determination of recurrence after therapy for prostate cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874236A (en) 1988-04-04 1999-02-23 Sibia Neurosciences. Inc. DNA encoding human calcium channel α-1A, β1, β-2, and β-4 subunits, and assays using cells that express the subunits
US5623051A (en) * 1994-11-10 1997-04-22 University Of Washington Methods and compositions for screening for presynaptic calcium channel blockers
JPH09299092A (ja) * 1996-03-12 1997-11-25 Takeda Chem Ind Ltd 新規タンパク質およびそのｄｎａ

Also Published As

Publication number Publication date
JP2003511087A (ja) 2003-03-25
WO2001027630A3 (en) 2001-12-06
ES2253263T3 (es) 2006-06-01
ATE312350T1 (de) 2005-12-15
CA2385907A1 (en) 2001-04-19
US6531288B1 (en) 2003-03-11
WO2001027630A2 (en) 2001-04-19
DE60024664T2 (de) 2006-07-06
EP1230551A2 (en) 2002-08-14
EP1230551B1 (en) 2005-12-07
DE60024664D1 (de) 2006-01-12

Similar Documents

Publication Publication Date Title
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
AU2003209636A1 (en) Novel chemokine binding peptides capable of modulating the biological activity of chemokines
AU6545898A (en) Method for identifying hormonally modulated genes
AU2002217010A1 (en) Peptides, the production and use thereof for binding immunoglobulins
AU4355697A (en) High level expression of proteins
AU2681497A (en) Novel agouti-related gene
AU2154801A (en) Method for linking molecular substances
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
MXPA00006306A (es) Compuestos del canal de ion del cerebro o corazon, regulados por nucleotidos ciclicos y usos de los mismos.
AU7896700A (en) Methods to identify compounds that modulate neuronal activity
MXPA01008605A (es) Proteina de enlace del antigeno goodpasture.
GB9816514D0 (en) Novel method
AUPP627498A0 (en) Novel peptides - i
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO2001088090A3 (en) Cng3b: a novel cyclic nucleotide-gated cation channel
TW200604207A (en) A superantigen fusion protein and the use thereof
AU2003221878A1 (en) G-protein coupled receptor ligands and methods
WO2001072826A3 (en) Oncogenic osteomalacia-related gene 1
WO2004078918A3 (en) Materials and methods relating to therapy and diagnosis using targeting of cells that express dcal-hy polypeptides
AU2001237438A1 (en) Potassium channel protein kcnq5, a target for diseases of central nervous systemand cardiovascular system
WO2004047758A3 (en) Methods of therapy and diagnosis using targeting of cells that express p2y10
WO2001098540A3 (en) Recombination modulators and methods for their production and use
EP0816498A3 (en) Excitatory amino acid receptor protein and related nucleic acid compounds
AU8488401A (en) Cng2b: a novel human cyclic nucleotide-gated ion channel
WO1998011131A3 (en) Nucleic acid encoding human neuronal calcium channel subunits

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase